{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:38:56Z","timestamp":1771051136407,"version":"3.50.1"},"reference-count":18,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>Human cytomegalovirus (HCMV) is a frequent participant in the infectious process in critically ill patients. This study aimed to determine the incidence of HCMV reactivation in critically ill patients and estimate the clinical effect of reactivation on the course of the pathological process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>To determine the incidence of HCMV reactivation, plasma and sputum samples were collected from 82 critically ill patients. HCMV reactivation was determined by quantitative PCR together with the presence of circulating HCMV IgG in the plasma. The statistical analysis of clinical data employed methods of descriptive (median with 95% confidence interval; minimum and maximum values, interquartile range) and nonparametric statistics [Mann-Whitney U test, odds ratio (OR), Kaplan\u2013Meier survival analysis].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>HCMV reactivation was found in 36.6 per cent of cases. An association between the presence of sepsis and the development of HCMV reactivation (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), as well as higher HCMV viral loads in septic patients, was found. There was also an association between the presence of HCMV DNA and the subsequent development of sepsis (OR=1.504). The involvement of HCMV in the emerging immunological shifts manifested by a decrease in CD8+ T-lymphocytes (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.01) and an increase in the immunoregulatory index (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.03) was found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>HCMV reactivation can influence the course of bacterial pathology with a deteriorating effect on such groups of patients. Monitoring the viral load of latent HCMV can be helpful in the assessment of the host immune status, the course of the pathological process, and its clinical prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1197_21","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T06:35:28Z","timestamp":1681108528000},"page":"771-778","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Reactivation of latent human cytomegaloviral infection in critically ill patients"],"prefix":"10.25259","volume":"156","author":[{"given":"Harbachou Viktar","family":"Uladzimiravich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitrachenko Tatyana","family":"Ivanovna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semenov Valery","family":"Mikhailovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahorau Siarhei","family":"Kanstantinavich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martov Vladimir","family":"Yurievich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornilov Artem","family":"Viktorovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-11-20241212","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00134-015-4071-z","article-title":"Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome","volume":"42","author":"Ong","year":"2016","journal-title":"Intensive Care Med"},{"key":"R2-11-20241212","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0310057X1604400525","article-title":"Cytomegalovirus reactivation in the critically ill septic intensive care patient: Pathogen or passenger?","volume":"44","author":"Heath","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"R3-11-20241212","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cix120","article-title":"Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock","volume":"64","author":"Ong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R4-11-20241212","doi-asserted-by":"crossref","first-page":"ofx029","DOI":"10.1093\/ofid\/ofx029","article-title":"Association between cytomegalovirus reactivation and clinical outcomes in immunocompetent critically ill patients: A systematic review and meta-analysis","volume":"4","author":"Lachance","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"R5-11-20241212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00134-015-4066-9","article-title":"Cytomegalovirus reactivation in ICU patients","volume":"42","author":"Papazian","year":"2016","journal-title":"Intensive Care Med"},{"key":"R6-11-20241212","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/CCM.0b013e31819ffea6","article-title":"Active cytomegalovirus infection is common in mechanically ventilated medical Intensive Care Unit patients","volume":"37","author":"Chiche","year":"2009","journal-title":"Crit Care Med"},{"key":"R7-11-20241212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13613-016-0207-8","article-title":"Cytomegalovirus infection in immunocompetent critically ill adults: Literature review","volume":"6","author":"Al-Omari","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R8-11-20241212","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R9-11-20241212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R10-11-20241212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.127.1.233","article-title":"Cytomegalovirus infection in critically ill patients: Associated factors and consequences","volume":"127","author":"Jaber","year":"2005","journal-title":"Chest"},{"key":"R11-11-20241212","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcrc.2014.10.002","article-title":"Cytomegalovirus reactivation in a general, nonimmunosuppressed Intensive Care Unit population: Incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers","volume":"30","author":"Frantzeskaki","year":"2015","journal-title":"J Crit Care"},{"key":"R12-11-20241212","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0310057X1604400514","article-title":"Cytomegalovirus infection in patients with sepsis due to bloodstream infections: Lower risk and better outcomes in new versus already hospitalised Intensive Care Unit admissions","volume":"44","author":"Osawa","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"R13-11-20241212","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4049\/jimmunol.177.3.1967","article-title":"Circulating cytokine\/inhibitor profiles reshape the understanding of the SIRS\/CARS continuum in sepsis and predict mortality","volume":"177","author":"Osuchowski","year":"2006","journal-title":"J Immunol"},{"key":"R14-11-20241212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00430-019-00603-y","article-title":"Impact of cytomegalovirus load on host response to sepsis","volume":"208","author":"Marandu","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"R15-11-20241212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00430-019-00600-1","article-title":"Role of antibodies in confining cytomegalovirus after reactivation from latency: Three decades'r\u00e9sum\u00e9","volume":"208","author":"Krmpoti\u0107","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"R16-11-20241212","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00134-015-4077-6","article-title":"Interferon-\u03b3production by CMV-specific CD8+T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients","volume":"42","author":"Cast\u00f3n","year":"2016","journal-title":"Intensive Care Med"},{"key":"R17-11-20241212","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/emm.2017.146","article-title":"Impaired polyfunctionality of CD8+ T cells in severe sepsis patients with human cytomegalovirus reactivation","volume":"49","author":"Choi","year":"2017","journal-title":"Exp Mol Med"},{"key":"R18-11-20241212","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/eji.201545495","article-title":"Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells","volume":"45","author":"Vieira Braga","year":"2015","journal-title":"Eur J Immunol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_1197_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:05:42Z","timestamp":1751497542000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/reactivation-of-latent-human-cytomegaloviral-infection-in-critically-ill-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1197_21","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}